26.59
price up icon3.79%   0.97
 
loading
Precedente Chiudi:
$25.62
Aprire:
$25.86
Volume 24 ore:
620.07K
Relative Volume:
0.48
Capitalizzazione di mercato:
$2.03B
Reddito:
-
Utile/perdita netta:
$-64.16M
Rapporto P/E:
-20.93
EPS:
-1.2702
Flusso di cassa netto:
$-69.06M
1 W Prestazione:
+4.52%
1M Prestazione:
-8.47%
6M Prestazione:
-25.66%
1 anno Prestazione:
-18.39%
Intervallo 1D:
Value
$25.47
$26.95
Intervallo di 1 settimana:
Value
$24.79
$26.95
Portata 52W:
Value
$14.80
$40.47

Cg Oncology Inc Stock (CGON) Company Profile

Name
Nome
Cg Oncology Inc
Name
Telefono
(949) 419-6203
Name
Indirizzo
400 SPECTRUM CENTER DRIVE, IRVINE
Name
Dipendente
113
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
CGON's Discussions on Twitter

Confronta CGON con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CGON
Cg Oncology Inc
26.59 1.95B 0 -64.16M -69.06M -1.2702
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.93 25.76B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.43 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.415 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.10 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.81 65.13B 14.09B 4.50B 2.96B 39.28

Cg Oncology Inc Stock (CGON) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-02 Iniziato JP Morgan Overweight
2025-04-16 Iniziato Scotiabank Sector Perform
2025-01-07 Iniziato TD Cowen Buy
2024-10-24 Iniziato UBS Buy
2024-09-23 Iniziato RBC Capital Mkts Outperform
2024-08-28 Iniziato ROTH MKM Buy
2024-06-28 Iniziato BofA Securities Buy
2024-02-20 Iniziato Cantor Fitzgerald Overweight
2024-02-20 Iniziato Goldman Neutral
2024-02-20 Iniziato Morgan Stanley Overweight
2024-02-14 Iniziato H.C. Wainwright Buy
Mostra tutto

Cg Oncology Inc Borsa (CGON) Ultime notizie

pulisher
Jun 02, 2025

Promising Market Position and Investment Opportunity: CG Oncology’s Creto in NMIBC Treatment - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

CG Oncology, Inc. (NASDAQ:CGON) Position Reduced by Nuveen Asset Management LLC - Defense World

Jun 02, 2025
pulisher
May 31, 2025

BNP Paribas Financial Markets Lowers Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 31, 2025
pulisher
May 29, 2025

CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

May 29, 2025
pulisher
May 27, 2025

CG Oncology’s SWOT analysis: bladder cancer treatment stock shows promise amid competition - Investing.com

May 27, 2025
pulisher
May 27, 2025

Bank of America Corp DE Has $6.01 Million Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 27, 2025
pulisher
May 27, 2025

Millennium Management LLC Invests $7.14 Million in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 27, 2025
pulisher
May 27, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 1,026 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 27, 2025
pulisher
May 26, 2025

CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success - MSN

May 26, 2025
pulisher
May 26, 2025

Deutsche Bank AG Acquires 13,589 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 26, 2025
pulisher
May 20, 2025

CG Oncology (NASDAQ:CGON) Given New $52.00 Price Target at Morgan Stanley - Defense World

May 20, 2025
pulisher
May 19, 2025

CGON Stock Rating Maintained by Morgan Stanley Despite Price Target Cut | CGON Stock News - GuruFocus

May 19, 2025
pulisher
May 18, 2025

Cantor Fitzgerald Lowers Earnings Estimates for CG Oncology - Defense World

May 18, 2025
pulisher
May 17, 2025

CG Oncology, Inc. (NASDAQ:CGON) Position Boosted by Northern Trust Corp - Defense World

May 17, 2025
pulisher
May 16, 2025

Q2 Earnings Forecast for CG Oncology Issued By HC Wainwright - Defense World

May 16, 2025
pulisher
May 15, 2025

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Leading Bladder Cancer Drug Developer CG Oncology Takes Stage at Major RBC Healthcare Conference - Stock Titan

May 15, 2025
pulisher
May 14, 2025

CG Oncology (NASDAQ:CGON) Shares Gap Down on Disappointing Earnings - Defense World

May 14, 2025
pulisher
May 14, 2025

Decoding CG Oncology Inc (CGON): A Strategic SWOT Insight - GuruFocus

May 14, 2025
pulisher
May 13, 2025

CG Oncology reports Q1 EPS (45c), consensus (37c) - TipRanks

May 13, 2025
pulisher
May 13, 2025

CGON Q1 Revenue Falls Short; Advances in Bladder Cancer Therapy - GuruFocus

May 13, 2025
pulisher
May 13, 2025

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates - ADVFN

May 13, 2025
pulisher
May 13, 2025

CG Oncology, Inc. (CGON) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

CG Oncology Q1 Loss Widens, Revenue Falls - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

CG Oncology, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025
pulisher
May 06, 2025

Here Are Reasons Why Cg Oncology Inc (NASDAQ: CGON) Is A Great Choice Now - Stocksregister

May 06, 2025
pulisher
May 05, 2025

CG Oncology Jumps 25% on Positive Trial Results - Orange County Business Journal

May 05, 2025
pulisher
May 05, 2025

CG Oncology (NASDAQ:CGON) Earns Overweight Rating from Analysts at JPMorgan Chase & Co. - Defense World

May 05, 2025
pulisher
May 04, 2025

CG Oncology, Inc. (NASDAQ:CGON) Given Consensus Recommendation of “Buy” by Analysts - Defense World

May 04, 2025
pulisher
May 03, 2025

CG Oncology, Inc. (NASDAQ:CGON) Shares Purchased by Invesco Ltd. - Defense World

May 03, 2025
pulisher
May 02, 2025

CG Oncology initiated with an Overweight at JPMorgan - TipRanks

May 02, 2025
pulisher
May 02, 2025

CGON Stock: JP Morgan Initiates Coverage with Overweight Rating - GuruFocus

May 02, 2025
pulisher
May 02, 2025

JPMorgan Initiates Coverage on CG Oncology With Overweight Rating, $41 Price Target - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

CGON: JPMorgan Starts Coverage with Overweight Rating and $41 Ta - GuruFocus

May 02, 2025
pulisher
May 02, 2025

CG Oncology (NASDAQ:CGON) Reaches New 1-Year Low After Insider Selling - Defense World

May 02, 2025
pulisher
May 02, 2025

CGON: JPMorgan Starts Coverage with Overweight Rating and $41 Target | CGON Stock News - GuruFocus

May 02, 2025
pulisher
May 01, 2025

Why CG Oncology, Inc. (CGON) Surged on Monday - MSN

May 01, 2025
pulisher
May 01, 2025

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

Cg Oncology Inc’s (CGON) Stock Is Harder To Predict Than You Think - Stocksregister

May 01, 2025
pulisher
May 01, 2025

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award - The Manila Times

May 01, 2025
pulisher
May 01, 2025

CG Oncology, Inc. (NASDAQ:CGON) Shares Bought by Wells Fargo & Company MN - Defense World

May 01, 2025
pulisher
Apr 30, 2025

A look into Cg Oncology Inc (CGON)’s deeper side - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Stock Performance Spotlight: Cg Oncology Inc (CGON) Ends the Day at 26.94, Down by -3.68 - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Could Cg Oncology Inc (NASDAQ: CGON) Be The Biggest Winner? - Marketing Sentinel

Apr 30, 2025
pulisher
Apr 30, 2025

Barclays PLC Acquires 10,737 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

CG Oncology's Bladder Cancer Drug Impresses InvestorsHere's Why - AOL.com

Apr 29, 2025
pulisher
Apr 29, 2025

Cg Oncology Inc [CGON] Stock sold by Insider POST LEONARD E for $28000.0 - knoxdaily.com

Apr 29, 2025
pulisher
Apr 29, 2025

CG Oncology, Inc. (CGON) Surges 25.0%: Is This an Indication of Further Gains? - MSN

Apr 29, 2025
pulisher
Apr 29, 2025

TD Cowen Sticks to Its Buy Rating for CG Oncology, Inc. (CGON) - The Globe and Mail

Apr 29, 2025
pulisher
Apr 29, 2025

CG Oncology (NASDAQ:CGON) Given Overweight Rating at Cantor Fitzgerald - Defense World

Apr 29, 2025

Cg Oncology Inc Azioni (CGON) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
Capitalizzazione:     |  Volume (24 ore):